[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100232347":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":17,"centralContacts":19,"locations":29,"responsibleParty":62,"collaborators":17,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":70,"eligibilityCriteria":71,"healthyVolunteers":66,"sex":72,"minAge":73,"maxAge":17,"enrollmentInfo":74,"targetDuration":17,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":83,"overallStatus":50,"whyStopped":17,"lastUpdateSubmitDate":88,"lastUpdatePostDateStruct":89,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},{"fullName":5,"class":6},"Hospices Civils de Lyon","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Functional autonomy level collection","EXPERIMENTAL","Collection of the Functional autonomy level every 6 - 12 months by phone",[13],"Other: The Lawton Instrumental Activities of Daily Living score (IADL), and the disability assessment of dementia score (DAD-6",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":17},"The Lawton Instrumental Activities of Daily Living score (IADL), and the disability assessment of dementia score (DAD-6",null,[9],[20,26],{"name":21,"role":22,"phone":23,"phoneExt":24,"email":25},"Pierre Krolak-Salmon, Professor","CONTACT","(0)4 72 43 20 50","+33","pierre.krolak-salmon@chu-lyon.fr",{"name":27,"role":22,"phone":23,"phoneExt":24,"email":28},"Virginie Dauphinot, Doctor","virginie.dauphinot@chu-lyon.fr",[30,48],{"facility":31,"status":32,"city":33,"state":17,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Hôpital Dugoujon","NOT_YET_RECRUITING","Caluire-et-Cuire","69300","France","FR",{"type":38,"coordinates":39},"Point",[40,41],4.8464,45.79462,{"lat":41,"lon":40},[44,46],{"name":45,"role":22,"phone":17,"phoneExt":17,"email":17},"Sylvain Gaujard",{"name":45,"role":47,"phone":17,"phoneExt":17,"email":17},"PRINCIPAL_INVESTIGATOR",{"facility":49,"status":50,"city":51,"state":17,"zip":17,"country":35,"countryCode":36,"cosmosGeoPoint":52,"geoPoint":56,"contacts":57},"Hospices Civils de Lyon - Hôpital des Charpennes","RECRUITING","Lyon",{"type":38,"coordinates":53},[54,55],4.84789,45.74906,{"lat":55,"lon":54},[58,60],{"name":59,"role":22,"phone":23,"phoneExt":24,"email":25},"Pierre KROLAK-SALMON, Pr",{"name":61,"role":22,"phone":23,"phoneExt":24,"email":28},"Virginie DAUPHINOT",{"type":63,"investigatorFullName":17,"investigatorTitle":17,"investigatorAffiliation":17,"oldNameTitle":17,"oldOrganization":17},"SPONSOR","100232347","predictive-factors-and-autonomy-level-change-100232347",false,"NCT02302482","Predictive Factors and Autonomy Level Change","Predictive Factors of the Autonomy Level Change Related to Memory Disorders","MEMORA","Inclusion Criteria:\n\n* Patients who undergo a medical visit in the Memory Clinic for the 1st time\n* Patients living at home or in housing\n* Patients with memory impairment, at all stage of the disease\n\nExclusion Criteria:\n\n* Patients in institution\n* Patients under legal protection\n* Patients with a hearing or visual impairment, which dot not allow to carry out the examination","ALL","65 Years",{"count":75,"type":76},10860,"ESTIMATED","INTERVENTIONAL",[79],"NA","The Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the disease, evaluated through its main symptoms, represents a major stake of public health. The investigators aimed at developing a database, which includes the patient medical records on a prospective basis, in collaboration with the medical and administrative personal and with the University hospital computer science department. The main objective is to study the predictive factors associated with the change of functional autonomy level, measured every 6 months to 12 months by phone, in a Memory Clinic. The study population would consist in about 1000 patients with ADRD. The length of follow-up of each patient will be 3 years.",[82],"Memory Impairment",[84,85,86,87],"Alzheimer's disease or related disorders","Functional autonomy level","Cognitive function","Predictive factors","2021-06-25",{"date":90,"type":91},"2021-06-28","ACTUAL",{"date":93,"type":91},"2014-11",{"date":95,"type":76},"2027-11",{"name":5,"class":6},2]